Oaktree Capital
SuperinvestorOaktree Capital Management LP
- SEC CIK
- 0000949509
- Manager
- Howard Marks
- Style
- Value
- Latest filing
- Aug 13, 2026
BTAIQ holding history
BioXcel Therapeutics, Inc. in every 13F filed by Oaktree Capital, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BTAIQ overviewAll 13F holders of BTAIQFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,380,248
- Value
- $1.95M
- % of portfolio
- <0.1%
- Quarters held
- 5
- Since Q2 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,380,248 | $1.95M | <0.1% | +1,139,060+472.3% | Added | Holders |
| Q1 2026 | 241,188 | $323.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 241,188 | $385.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 241,188 | $617.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 241,188 | $436.6K | <0.1% | +241,188 | New | Holders |